The transition from the esophagus to the stomach is a delicate region from a medical point of view, often associated with pathological disorders leading to cancer. An international research team has now gained new insights ...
Apr 11, 2024
0
12
Esophageal squamous cell carcinoma (ESCC) accounts for around 90% of esophageal cancers, especially in East Asia. New findings indicate that periostin, or POSTN, promotes ESCC progression by enhancing cancer and stromal cell ...
Apr 9, 2024
0
1
A multidisciplinary team of researchers that included 14 graduate students from The University of Texas at Arlington has created a new framework to provide optimal personalized treatment options for individuals with esophageal ...
Jan 31, 2024
0
0
Drinking alcohol—even in moderation—can take a serious toll on the body. According to the National Cancer Institute, there is a strong scientific consensus that drinking alcohol increases the risk for several types of ...
Jan 30, 2024
0
1
A team of Northwestern Medicine investigators have successfully localized novel molecular mechanisms behind a genetic mutation found in a wide range of cancers, which could serve as a biomarker for improving patient stratification ...
Dec 21, 2023
0
35
Combining a PD-1 immune checkpoint inhibitor with standard chemotherapy improved quality of life for patients with advanced stomach cancer or esophageal cancer compared to chemotherapy alone, according to recent findings ...
Oct 12, 2023
0
1
Studying genes in families with a propensity for certain diseases has led to many critical advances in medicine, including the discovery of statins in family members who suffered heart attacks at an early age.
Sep 19, 2023
0
1
Reflux disease manifests as acid regurgitation and heartburn and is a known risk factor for esophageal cancer. However, a new study published in The BMJ by researchers at Karolinska Institutet now reports that the majority ...
Sep 13, 2023
0
48
Cancer's global impact is severe, affecting millions worldwide and driving cancer research to the forefront of biomedical science.
Sep 12, 2023
0
6
A 67-year old patient presenting with esophageal cancer has been treated at the Paul Scherrer Institute PSI with a form of radiation provided by protons, i.e., positively charged particles. This is the first time this type ...
Aug 16, 2023
0
4
Esophageal cancer is malignancy of the esophagus. There are various subtypes, primarily squamous cell cancer and adenocarcinoma. Squamous cell cancer arises from the cells that line the upper part of the esophagus. Adenocarcinoma arises from glandular cells that are present at the junction of the esophagus and stomach. Esophageal tumors usually lead to dysphagia (difficulty swallowing), pain and other symptoms, and are diagnosed with biopsy. Small and localized tumors are treated surgically with curative intent. Larger tumors tend not to be operable and hence cannot be cured; their growth can still be delayed with chemotherapy, radiotherapy or a combination of the two. In some cases chemo- and radiotherapy can render these larger tumors operable. Prognosis depends on the extent of the disease and other medical problems, but is fairly poor.
This text uses material from Wikipedia, licensed under CC BY-SA
